Guangdong Hec Technology Holding Co Ltd
SSE:600673
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Guangdong Hec Technology Holding Co Ltd
Free Cash Flow
Guangdong Hec Technology Holding Co Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Guangdong Hec Technology Holding Co Ltd
SSE:600673
|
Free Cash Flow
-¥98.3m
|
CAGR 3-Years
29%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
C
|
China Hongqiao Group Ltd
HKEX:1378
|
Free Cash Flow
¥25B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Aluminum Corporation of China Ltd
SSE:601600
|
Free Cash Flow
¥30.5B
|
CAGR 3-Years
18%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Shandong Hongchuang Aluminum Industry Holding Co Ltd
SZSE:002379
|
Free Cash Flow
¥18.6B
|
CAGR 3-Years
332%
|
CAGR 5-Years
235%
|
CAGR 10-Years
N/A
|
|
|
Yunnan Aluminium Co Ltd
SZSE:000807
|
Free Cash Flow
¥9.6B
|
CAGR 3-Years
19%
|
CAGR 5-Years
41%
|
CAGR 10-Years
13%
|
|
|
Tianshan Aluminum Group Co Ltd
SZSE:002532
|
Free Cash Flow
¥6.5B
|
CAGR 3-Years
87%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
Guangdong Hec Technology Holding Co Ltd
Glance View
Nestled in the vibrant economic landscape of China, Guangdong Hec Technology Holding Co Ltd operates with the intricacies of a well-oiled machine in the health sector. The company, with its focal point in pharmaceuticals, has been a significant player in the development, manufacturing, and sale of a variety of medicinal products. Its portfolio spans across anti-infectives, digestive medications, and cardiovascular treatments, amassing a reputation for innovation and quality. The company’s commitment to research and development is palpable, as it consistently invests in state-of-the-art laboratories and collaborations with leading scientific minds. This approach not only fuels its pipeline of groundbreaking therapies but also ensures a steady stream of products ready for market. The company's revenue engine hums efficiently through a strategic blend of domestic and international market penetration. By leveraging an extensive distribution network, Guangdong Hec Technology ensures its products reach both regional pharmacies and global pharmaceutical markets. Through meticulous marketing strategies and strategic partnerships, the company has adeptly navigated the complex waters of regulatory compliance and competitive pricing landscapes. Its financial fortitude is further bolstered by a judicious mix of pharmaceutical exports and local sales, highlighting its dual focus on global expansion and domestic consolidation. In this dance of science and commerce, Guangdong Hec Technology continues to solidify its stature, harnessing both innovation and keen business acumen to thrive in the ever-evolving pharmaceutical industry.
See Also
What is Guangdong Hec Technology Holding Co Ltd's Free Cash Flow?
Free Cash Flow
-98.3m
CNY
Based on the financial report for Dec 31, 2025, Guangdong Hec Technology Holding Co Ltd's Free Cash Flow amounts to -98.3m CNY.
What is Guangdong Hec Technology Holding Co Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
39%
Over the last year, the Free Cash Flow growth was 83%. The average annual Free Cash Flow growth rates for Guangdong Hec Technology Holding Co Ltd have been 29% over the past three years , 39% over the past five years .